AI assistant
Sending…
BioInvent International — Major Shareholding Notification 2021
Mar 2, 2021
3011_iss_2021-03-02_fcfc0c40-a450-4135-a1a3-27ffb4595006.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer BioInvent International Aktiebolag
Holder
Redmile Group, LLC
Instrument
| Instrument | Common shares SE0015244520 |
|---|---|
| Before the transaction | |
| Shares | 0 |
| Voting rights | 0 |
| Transaction | |
| Reason for major shareholding notification Other | |
| Date | 01/03/2021 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 2,834,399 |
| Directly held voting rights | 2,834,399 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 6.71492 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 6.71492 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 6.71492 % | 2,834,399 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
Total 6.71492 % 2,834,399
Chain of controlling companies
Voting rights % Voting rights Company
| 49,245 | 0.11667 | Redmile Capital Offshore Fund (ERISA), Ltd. |
|---|---|---|
| 103,253 | 0.24461 | Map 20 Segregated Portfolio, a segregated portfolio of LMA SPC |
| 1,256,778 2.97741 | Redmile Capital Offshore Master Fund, Ltd. | |
| 43,620 | 0.10334 | Redmile Capital Offshore II Master Fund, Ltd. |
| 600,411 | 1.42242 | Redmile Capital Fund, LP |
| 481,468 | 1.14064 | Redmile Strategic Master Fund, LP |
| 299,624 | 0.70983 | Redmile Capital Offshore II Master Fund, Ltd. (Strategic Sleeve) |
| total holdings Group |
||
| Voting rights | 2,834,399 |
Percentage of voting rights 6.71492
Notes (other relevant informations according to law)
Changes due to: Directed rights issue
Published
02/03/2021 17:02

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from BioInvent International
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 29
AGM Information
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 24
Proxy Solicitation & Information Statement
2026
Mar 24
Interim / Quarterly Report
2026
Feb 26